GC Pharma Lenvervimab (GC1102) Humanized IgG1 Hepatitis B virus surface antigen Phase 2/3 Hepatitis B virus-associated liver transplant (NCT03519113) Novartis Pharmaceuticals Corp. Ligelizumab Human IgG1 IgE Phase 3 Chronic spontaneous urticaria (NCT03907878, NCT03580356, NCT04210843, NCT03580369)...
We proposed screening for agents that enhancep21promoter activity to Astellas Pharma Inc. We identified YM753, originally discovered as spiruchostatin A (Masuoka et al., 2001), as a novelHDACinhibitor (Shindoh et al., 2008). YM753 exhibited 50-fold higher inhibitory activity against HDAC than...
奥布替尼: 一种BTK抑制剂药物,由Beijing InnoCare Pharma Tech Co., Ltd. (北京诺诚健华医药科技有限公司)公司最早进行研发,目前全球最高研发状态为批准上市,作用机制: BTK抑制剂(酪氨酸蛋白激酶BTK抑制剂),治疗领域: 肿瘤,免疫系统疾病,血液及淋巴系统疾病,其他疾病,心
Viral supernatant was generated by the use of the producer cell line 293VEC-RD114 (kindly provided by BioVec Pharma, Canada). Phenotypic analysis Expression of cell surface molecules was determined by flow-cytometry using standard methodology. The mAbs used in this study were listed in ...
the cumulative of all of these, if they all actually made it to market and got approved, have peak sales cumulatively of about $14 billion. And when you consider that our pharma business today is about $7.5 billion, this late-stage pipeline could really transform Biogen over the longer term...
a similar reduction of Th2 cells was observed in theIl2ra+/−OT-II cells in both papain- and FCA-immunized mice (Fig.3j). Likewise, there was no significant difference in the reduction in Th1 cells in theIl2ra+/−OT-II cells between papain-, FCA- and CpG-immunized mice when norma...
B., Rendenbach-Mueller, B., Katz, D. A., Tracy, K. A., . . . Litten, R. Z. (2017). A phase 2, double-blind, placebo- controlled randomized trial assessing the efficacy of ABT-436, a novel V1b receptor antagonist, for alcohol dependence. Neuropsychopharma- cology, 42, 1012-...
and Heidelberg Pharma; and advisory board participation for Genentech, Janssen, and Bristol Myers Squibb. S.K. reports consulting with no personal payment from AbbVie, Amgen, ArcellX, Beigene, Bristol Myers Squibb, Carsgen, GSK, Janssen, K36, Moderna, Pfizer, Regeneron, Roche-Genentech, Sanofi...
Precision Medicine in Oncology® Sarcomas Supportive Care Spotlight - In-person and virtual events just for HCPs CME Opportunities Choose Specialty Newsletter Stay up to date on the most recent and practice-changing oncology data Subscribe Now!
1 A–B). There was a slight downward trend in niraparib-treated patients for fatigue LS mean change from baseline scores from cycle 3 to cycle 18, indicating symptom improvement; placebo LS mean change from baseline scores remained consistent through cycle 18 and showed no difference compared ...